Ticker
TMCICompany Name
TREACE MEDICAL CONCEPTS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 11.73M | $ -43.92M | $ -32.19M |
3/31/2025 | $ 11.31M | $ -47.74M | $ -36.43M |
12/31/2024 | $ 10.77M | $ -50.49M | $ -39.72M |
9/30/2024 | $ 9.15M | $ -56.28M | $ -47.13M |
6/30/2024 | $ 9.74M | $ -58.45M | $ -48.72M |
3/31/2024 | $ 8.76M | $ -49.55M | $ -40.79M |
12/31/2023 | $ 7.81M | $ -44.36M | $ -36.55M |
9/30/2023 | $ 6.88M | $ -42.48M | $ -35.6M |
6/30/2023 | $ 6.02M | $ -37.2M | $ -31.19M |
3/31/2023 | $ 5.54M | $ -42.5M | $ -36.97M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for TREACE MEDICAL CONCEPTS INC is calculated as follows: EBIT [ $ -891K ] + DepAmor [ $ 1.21M ]
(=) EBITDA [ $ 319K ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.8M |
median | $ 8.83M |
std | $ 166.97M |